http://www.neurocrine.com
Neurocrine Biosciences, Inc. Company Intro
Neurocrine discovers and develops pharmaceutical through its R&D platform, focused on neurological and endocrine based diseases and disorders. Learn more.
Industry
Healthcare
Neurocrine Biosciences, Inc. Headquaters
12780 El Camino Real
San Diego,92130
United States
Neurocrine Biosciences, Inc. Share price
17 May 2023 13:35 GMT
$97.38
3.05 (3.23 %)
Neurocrine Biosciences, Inc. Market cap
$9.165 B
WMC RANKING
2023
Neurocrine Biosciences, Inc. # 11
BiotechnologyLatest Neurocrine Biosciences, Inc. News
30 Nov 2023
Analysts: NBIX stock price target of $135.44 in 12 months ...
Investors can expect a company's stock to rise or fall based on the buying and selling of stock by its insiders. Neurocrine Biosciences, Inc. shares valued...
30 Nov 2023
Views of Wall Street's Leading Experts on Neurocrine ...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stock jumped 0.62% on Wednesday to $113.54 against a previous-day closing price of $112.84.
30 Nov 2023
Guru Fundamental Report for NBIX
NEUROCRINE BIOSCIENCES, INC. (NBIX) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 66% based on the...
WMC Market Score
WMC Market to Revenue Score
Neurocrine Biosciences, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Neurocrine Biosciences, Inc. | USD | $1,045,400 | $734,400 | $402,000 | $91,650B | 11 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Neurocrine Biosciences, Inc. Social Followers vs Top 4 Industry Competitors
Neurocrine Biosciences, Inc. Post vs Top 4 Industry Competitors
Neurocrine Biosciences, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Neurocrine Biosciences, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Neurocrine Biosciences, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Neurocrine Biosciences, Inc. | 11.37 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
